BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6328884)

  • 1. Tumor markers in colorectal carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
    Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
    Acta Radiol Oncol; 1984; 23(1):27-32. PubMed ID: 6328884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers in bronchogenic carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
    Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
    Acta Radiol Oncol; 1983; 22(3):209-14. PubMed ID: 6312760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor markers in mammary carcinoma. An evaluation of carcinoembryonic antigen, placental alkaline phosphatase, pseudouridine and CA-50.
    Rasmuson T; Björk GR; Damber L; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
    Acta Oncol; 1987; 26(4):261-7. PubMed ID: 3479987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
    Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
    J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
    Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
    J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
    [No Abstract]   [Full Text] [Related]  

  • 6. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
    Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
    Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer].
    Yukawa H; Kono N; Taniguchi K; Ieda K; Ono K; Yamamoto S; Koh K; Ohta M; Hayashido M; Yamaguchi K
    Nihon Geka Hokan; 1984 Mar; 53(2):433-6. PubMed ID: 6508467
    [No Abstract]   [Full Text] [Related]  

  • 8. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
    Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Tamsen L
    Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma.
    Putzki H; Student A; Jablonski M; Heymann H
    Cancer; 1987 Jan; 59(2):223-6. PubMed ID: 3467817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase, and modified nucleosides as biological markers in malignant lymphomas.
    Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Littbrand B; Stigbrand T; Westman G
    Recent Results Cancer Res; 1983; 84():331-43. PubMed ID: 6342073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) in different types of cancer.
    Falcone F; Sabbatani S; Fini A; Turba E; Magri P; D'Ales A
    Nucl Med Commun; 1985 May; 6(5):299-304. PubMed ID: 4034127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen (CEA) and alkaline phosphatase in progressive colorectal cancer with special reference to patient survival.
    Aabo K; Pedersen H; Kjaer M
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):211-7. PubMed ID: 3699082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery.
    Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U
    Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9.
    Buccheri GF; Ferrigno D; Sartoris AM; Violante B; Vola F; Curcio A
    Cancer; 1987 Jul; 60(1):42-50. PubMed ID: 3472637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers.
    Hørding U; Toftager-Larsen K; Dreisler A; Lund B; Daugaard S; Lundvall F; Arends J; Winkel P; Rørth M
    Gynecol Obstet Invest; 1990; 30(3):178-83. PubMed ID: 2265805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
    Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
    Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma.
    Shani A; O'Connell MJ; Moertel CG; Schutt AJ; Silvers A; Go VL
    Ann Intern Med; 1978 May; 88(5):627-30. PubMed ID: 646245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary pseudouridine/creatinine ratio as an indicator of gastrointestinal cancer.
    Higley B; De Mello J; Oakes DJ; Giles GR
    Br J Surg; 1982 Dec; 69(12):699-701. PubMed ID: 7171969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.